131 results
DynaMed Founder Dr. Brian Alper takes on a new challenge leaving EBSCO after 15 years to change knowledge development.
Read about a large, real-time public health study evaluating effectiveness of a third (booster) dose of Pfizer COVID-19 vaccine from the EBM Focus team at DynaMed®.
The latest EBM Focus article dissects an interrupted time series analysis to explore whether COVID vaccines improve symptoms of long COVID.
In this EBM Focus, DynaMed® editors evaluate a test-negative case-control study evaluating vaccine effectiveness against alpha and delta variants of SARS-COV-2.
In this EBM Focus article, we delve into the hypothesis that ACE inhibitors could be associated with severe COVID-19, and a study that lets ACE inhibitors off the hook.
Help your patients make an informed choice about the COVID-19 vaccine with a decision aid created by EBSCO Clinical Decisions.
Do you know which disease name reflects an evil influence from the sky? Dr. Steve Berger from GIDEON (Global Infectious Diseases and Epidemiology Online Network) delves into the history of disease nomenclature, including the most recent — COVID-19
With millions of people around the world vaccinated with an adenovirus-vectored vaccine for COVID-19, here’s a sneak peek into the body to see how they work.
Cases of viral rebound or COVID rebound are being reported after Paxlovid therapy. Here’s what healthcare practitioners should know about Paxlovid efficacy and rebound.
Like other respiratory infections, tuberculosis (TB) cases plummeted during the COVID-19 pandemic. However, unlike other infections, it is likely that TB incidence actually increased due to pandemic-related disruptions in healthcare.